质量即生命 — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

成为合作伙伴
ALIPONATIB 45mg
Rx
肿瘤学 & 血液学

ALIPONATIB 45mg

普纳替尼 (Ponatinib)
Generic (INN)
普纳替尼 (Ponatinib)
Strength
45 mg
Packaging
30片/瓶。
Indication
ALIPONATIB-45 是一种激酶抑制剂，用于治疗符合以下条件的成年患者：对既往酪氨酸激酶抑制剂治疗耐药或不耐受的慢性期、加速期或急变期慢性髓细胞白血病（CML）。
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in 肿瘤学 & 血液学

View all →
ALIIVOSIDENIB
ALIIVOSIDENIB
艾伏尼布 (Ivosidenib)
ALIERDATINI 3mg
ALIERDATINI 3mg
厄达替尼 (Erdafitinib)
ARIMIDEX
ARIMIDEX
阿那曲唑 (Anastrozole)
ALIGIRITINIB
ALIGIRITINIB
吉列替尼 (Gilteritinib)
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Stem Cell CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Stem Cell Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文